Contact Us

Experimental drug slows progression of Alzheimer’s: Study

An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.

  • 1
  • 8
The experimental drug lecanemab has the "potential" to serve as treatment at early stages of Alzheimer's disease, according to new trial results.